Eli Lilly said on Tuesday its experimental GLP-1 pill helped overweight adults with type 2 diabetes shed 10.5% of body weight ...

Ecnoglutide, a novel once-weekly injection for type 2 diabetes management, works as well as dulaglutide (a commonly ...

New data from Eli Lilly says its daily, oral GLP-1 pill may help people who have obesity and people who have Type 2 diabetes ...

Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the Phase 3 ATTAIN-2 trial, evaluating ...

Like semaglutide, the new drug known as ecnoglutide is glucagon-like peptide-1 receptor agonist. In simple terms, they both ...

Currently, stem cells and transplants are reserved for people whose diabetes cannot be controlled by the standard treatments.

India faces a diabetes crisis. Regular blood sugar monitoring is vital. HbA1c offers a long-term view. SMBG provides daily ...

New recommendations suggest holding back on SGLT2 inhibitors and GLP-1s among those at a lower risk for cardiovascular or ...

Low blood sugar (hypoglycaemia) can occur even without diabetes. Learn about its causes, symptoms, risks, and when to seek ...

Some foods and drinks interfere with the way some diabetes medications work. High fat meals, alcohol and refined carbs can ...

Treatment-induced neuropathy of diabetes (TIND) is a rare but potentially painful complication of diabetes caused by high blood sugar and nerve damage. Treatment-induced neuropathy of diabetes ...